252 related articles for article (PubMed ID: 30422249)
1. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
2. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
[TBL] [Abstract][Full Text] [Related]
4. Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Pukkala E; Romundstad P; Tryggvadóttir L; Euler-Chelpin MV; Lagergren J
Ann Surg; 2022 Aug; 276(2):e79-e85. PubMed ID: 33074906
[TBL] [Abstract][Full Text] [Related]
5. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study.
Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Nwaru B; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Eur J Cancer; 2020 Oct; 138():80-88. PubMed ID: 32877797
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE; Lu Y; Lagergren P; Lagergren J
Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349
[TBL] [Abstract][Full Text] [Related]
8. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
[TBL] [Abstract][Full Text] [Related]
9. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
Ye W; Chow WH; Lagergren J; Yin L; Nyrén O
Gastroenterology; 2001 Dec; 121(6):1286-93. PubMed ID: 11729107
[TBL] [Abstract][Full Text] [Related]
10. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
11. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux.
Maret-Ouda J; Wahlin K; El-Serag HB; Lagergren J
JAMA; 2017 Sep; 318(10):939-946. PubMed ID: 28898377
[TBL] [Abstract][Full Text] [Related]
12. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?
Lagergren J; Viklund P
World J Surg; 2007 Mar; 31(3):465-9. PubMed ID: 17171490
[TBL] [Abstract][Full Text] [Related]
13. Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus.
Åkerström JH; Santoni G; von Euler Chelpin M; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J
Gastroenterology; 2024 Jan; 166(1):132-138.e3. PubMed ID: 37690771
[TBL] [Abstract][Full Text] [Related]
14. The risk of esophageal adenocarcinoma after antireflux surgery.
Lagergren J; Ye W; Lagergren P; Lu Y
Gastroenterology; 2010 Apr; 138(4):1297-301. PubMed ID: 20080091
[TBL] [Abstract][Full Text] [Related]
15. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
16. Aspiration pneumonia after antireflux surgery among neurologically impaired children with GERD.
Maret-Ouda J; Santoni G; Artama M; Ness-Jensen E; Svensson JF; von Euler-Chelpin M; Lagergren J
J Pediatr Surg; 2020 Nov; 55(11):2408-2412. PubMed ID: 32037217
[TBL] [Abstract][Full Text] [Related]
17. Decreased Risk of Esophageal Adenocarcinoma After Gastric Bypass Surgery in a Cohort Study From 3 Nordic Countries.
Hardvik Åkerström J; Santoni G; von Euler Chelpin M; Chidambaram S; Markar SR; Maret-Ouda J; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J
Ann Surg; 2023 Dec; 278(6):904-909. PubMed ID: 37450697
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
19. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease.
Holmberg D; Santoni G; von Euler-Chelpin MC; Färkkilä M; Kauppila JH; Maret-Ouda J; Ness-Jensen E; Lagergren J
Gastroenterology; 2022 Feb; 162(2):431-438.e4. PubMed ID: 34627859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
